Published in Exp Mol Med on March 31, 2010
FGF signaling activates a Sox9-Sox10 pathway for the formation and branching morphogenesis of mouse ocular glands. Development (2014) 0.91
Enhanced cartilage regeneration in MIA/CD-RAP deficient mice. Cell Death Dis (2010) 0.91
Development of a model system to analyze chondrogenic differentiation of mesenchymal stem cells. Int J Clin Exp Pathol (2013) 0.83
Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis (2015) 0.80
MIA is a potential biomarker for tumour load in neurofibromatosis type 1. BMC Med (2011) 0.79
Identification of putative retinoic acid target genes downstream of mesenchymal Tbx1 during inner ear development. Dev Dyn (2012) 0.79
YBX1 is a modulator of MIA/CD-RAP-dependent chondrogenesis. PLoS One (2013) 0.77
Influence of cryopreservation, cultivation time and patient's age on gene expression in Hyalograft® C cartilage transplants. Int Orthop (2013) 0.76
Paracrine Potential of the Human Adipose Tissue-Derived Stem Cells to Modulate Balance between Matrix Metalloproteinases and Their Inhibitors in the Osteoarthritic Cartilage In Vitro. Stem Cells Int (2017) 0.75
Redifferentiation of aged human articular chondrocytes by combining bone morphogenetic protein-2 and melanoma inhibitory activity protein in 3D-culture. PLoS One (2017) 0.75
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol (2007) 8.08
Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum (1992) 2.10
Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum (2002) 1.81
The vascularity and remodelling of subchondrial bone and calcified cartilage in adult human femoral and humeral heads. An age- and stress-related phenomenon. J Bone Joint Surg Br (1977) 1.45
Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res (1994) 1.32
Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner (1991) 1.31
Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins. Proc Natl Acad Sci U S A (2001) 1.22
The morphology of the calcification front in articular cartilage. Its significance in joint function. J Bone Joint Surg Br (1983) 1.18
The ultrastructure of mouse articular cartilage: collagen orientation and implications for tissue functionality. A polarised light and scanning electron microscope study and review. Eur Cell Mater (2005) 1.17
Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun (2000) 1.13
Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn (1997) 1.11
Integrin-mediated signalling through the MAP-kinase pathway. IET Syst Biol (2008) 1.11
Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis. J Biol Chem (1996) 1.10
Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity. Lab Invest (2003) 1.10
Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. Mol Cell Biol (2002) 1.06
Localization of type X collagen in canine growth plate and adult canine articular cartilage. J Orthop Res (1991) 1.03
The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold. EMBO J (2001) 1.01
Expression of type-X collagen in osteoarthritis. J Orthop Res (1995) 1.00
Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA. Exp Cell Res (2005) 1.00
The MEK-ERK signaling pathway is a negative regulator of cartilage-specific gene expression in embryonic limb mesenchyme. J Biol Chem (2003) 0.97
Regulation of integrin activity by MIA. J Biol Chem (2006) 0.92
Metabolic activity in the calcified zone of cartilage: observations on tetracycline labelled articular cartilage in human osteoarthritic hips. Rheumatol Int (1990) 0.90
Establishing the protein MIA (melanoma inhibitory activity) as a marker for chondrocyte differentiation. Biomaterials (2003) 0.89
The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol (2000) 0.88
Skeletal unloading induces a full-thickness patellar cartilage defect with increase of urinary collagen II CTx degradation marker in growing rats. Bone (2008) 0.87
Isolation of human type X collagen and immunolocalization in fetal human cartilage. Eur J Biochem (1991) 0.87
The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. FEBS J (2009) 0.86
Extracellular SH3 domain containing proteins--features of a new protein family. Curr Protein Pept Sci (2008) 0.84
Effects of mechanical stimuli on adaptive remodeling of condylar cartilage. J Dent Res (2009) 0.83
Detailed analysis of MIA protein by mutagenesis. Biol Chem (2006) 0.81
Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Radiother Oncol (2006) 1.94
The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J (2002) 1.72
Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol (2002) 1.62
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res (2004) 1.61
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci (2009) 1.60
Multiparameter immunofluorescence on paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol (2006) 1.59
Integrin signaling in malignant melanoma. Cancer Metastasis Rev (2005) 1.58
Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res (2005) 1.49
Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. J Am Coll Cardiol (2008) 1.43
Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion (2003) 1.41
Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol (2003) 1.36
Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol (2008) 1.27
Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol (2009) 1.19
MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci (2010) 1.16
MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer (2011) 1.12
Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology (2009) 1.11
Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One (2009) 1.10
Epigenetic events in malignant melanoma. Pigment Cell Res (2007) 1.10
Cold atmospheric plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo. PLoS One (2013) 1.09
Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis (2005) 1.09
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol (2009) 1.08
Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. Mol Cell Biol (2002) 1.06
A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol (2006) 1.06
Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells. Exp Dermatol (2013) 1.04
Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling. Mol Cell Neurosci (2007) 1.03
p54nrb is a new regulator of progression of malignant melanoma. Carcinogenesis (2011) 1.01
Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer (2010) 0.99
Multiple substance use among young males. Pharmacol Biochem Behav (2006) 0.98
Collagen IX-deficiency seriously compromises growth cartilage development in mice. Matrix Biol (2008) 0.98
Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon. Dev Dyn (2004) 0.98
Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J (2004) 0.97
Extended indications for nipple-sparing mastectomy. Breast J (2011) 0.97
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci U S A (2012) 0.96
BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. Exp Mol Pathol (2011) 0.95
Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels. Cell Res (2010) 0.94
Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications. Ann Surg (2009) 0.93
Characterization of Sno expression in malignant melanoma. Int J Oncol (2005) 0.93
Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissues. Lab Invest (2005) 0.93
Regulation of integrin activity by MIA. J Biol Chem (2006) 0.92
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol (2005) 0.91
Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One (2013) 0.91
Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation. Cardiovasc Res (2004) 0.90
Deregulation of protein methylation in melanoma. Eur J Cancer (2012) 0.90
The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis Rheum (2009) 0.89
Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes. J Leukoc Biol (2007) 0.89
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Liver Int (2005) 0.89
A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning. PLoS One (2011) 0.88
Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin. Lab Invest (2005) 0.88
Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. Am J Pathol (2010) 0.88
Processing of MIA protein during melanoma cell migration. Int J Cancer (2009) 0.87
Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration. Cancer Sci (2009) 0.86
Impact of the reconstruction method on delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: a prospective randomized study. World J Surg (2014) 0.86
Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients. Radiother Oncol (2008) 0.85
Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells. J Vasc Res (2002) 0.85
Coffee consumption induces GSTP in plasma and protects lymphocytes against (+/-)-anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide induced DNA-damage: results of controlled human intervention trials. Mutat Res (2005) 0.84
Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. Dev Biol (2008) 0.84
Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases. Exp Dermatol (2012) 0.84
Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. J Neurooncol (2005) 0.84
Coculture between periosteal explants and articular chondrocytes induces expression of TGF-beta1 and collagen I. Rheumatology (Oxford) (2009) 0.84
The evolving concept of 'melano-miRs'-microRNAs in melanomagenesis. Pigment Cell Melanoma Res (2010) 0.83
Development of a model system to analyze chondrogenic differentiation of mesenchymal stem cells. Int J Clin Exp Pathol (2013) 0.83
FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. Oncol Rep (2010) 0.83
Fussel-15, a new player in wound healing, is deregulated in keloid and localized scleroderma. Am J Pathol (2011) 0.83
Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts. Eur J Cancer (2008) 0.82
Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines. World J Gastroenterol (2006) 0.82
Expression and function of the atypical cadherin FAT1 in chronic liver disease. Biochem Biophys Res Commun (2012) 0.82
The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center. Anticancer Res (2013) 0.81
Blue- and green-light signals for gamete release in the brown alga, Silvetia compressa. Oecologia (2003) 0.81
Detailed analysis of MIA protein by mutagenesis. Biol Chem (2006) 0.81
Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma. Lab Invest (2011) 0.81
A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content. ACS Chem Neurosci (2012) 0.80
Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma. Oncol Rep (2004) 0.79
Melanoma inhibitory activity promotes melanoma development through activation of YBX1. Pigment Cell Melanoma Res (2013) 0.79
The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial. Thromb Haemost (2010) 0.79
Decrease of vascular smooth muscle cell locomotion by abciximab, but not tirofiban: a possible role of different affinity to alpha v beta 3 integrins. Coron Artery Dis (2002) 0.79
Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines. Strahlenther Onkol (2015) 0.79
Alpha-tocopherol in plasma, red blood cells and lenses with and without cataract. Am J Ophthalmol (2005) 0.78
Collagen XVI is a neural component of the developing and regenerating dorsal root ganglia extracellular matrix. Matrix Biol (2006) 0.78
Analysis of bone matrix composition and trabecular microarchitecture of the femoral metaphysis in patients with osteonecrosis of the femoral head. J Orthop Res (2009) 0.78
Expression and function of methylthioadenosine phosphorylase in chronic liver disease. PLoS One (2013) 0.78
Expression patterns of integrins on quiescent and invasive smooth muscle cells and impact on cell locomotion. J Mol Cell Cardiol (2002) 0.78
Influence of factors regulating bone formation and remodeling on bone quality in osteonecrosis of the femoral head. Calcif Tissue Int (2008) 0.78
Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains. Protein Sci (2003) 0.78
Distal gastrectomy in pancreaticoduodenectomy is associated with accelerated gastric emptying, enhanced postprandial release of GLP-1, and improved insulin sensitivity. J Gastrointest Surg (2013) 0.77
MIA--a new target protein for malignant melanoma therapy. Histol Histopathol (2012) 0.77
Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol (2002) 0.77
Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways. World J Gastroenterol (2005) 0.77
Empirical multidimensional space for scoring peptide spectrum matches in shotgun proteomics. J Proteome Res (2014) 0.77
The effect of a bolus dose of intravenous lidocaine on the minimum alveolar concentration of sevoflurane: a prospective, randomized, double-blinded, placebo-controlled trial. Anesth Analg (2013) 0.77
Role of deleted in colon carcinoma in osteoarthritis and in chondrocyte migration. Rheumatology (Oxford) (2009) 0.77
Epidemiology of substance use in a representative sample of 18-year-old males. Alcohol Alcohol (2005) 0.77
3D-conformal radiotherapy for prevention of carotid recurrent in-stent restenosis. Initial experience. Wien Klin Wochenschr (2005) 0.76
Collagen XVI induces formation of focal contacts on intestinal myofibroblasts isolated from the normal and inflamed intestinal tract. Matrix Biol (2009) 0.76
Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma. Melanoma Res (2006) 0.76
fussel (fuss)--A negative regulator of BMP signaling in Drosophila melanogaster. PLoS One (2012) 0.75
Martin Humphries: Attached to adhesion. Interview by Caitlin Sedwick. J Cell Biol (2013) 0.75
Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates. Transfusion (2005) 0.75